Short Chain Fatty Acids Enhance Aryl Hydrocarbon (Ah) Responsiveness in Mouse Colonocytes and Caco-2 Human Colon Cancer Cells

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Jin, Un Ho ^a   Cheng, Yating ^a   Park, Hyejin ^a   Davidson, Laurie A ^b   Callaway, Evelyn S ^b   Chapkin, Robert S ^b   Jayaraman, Arul ^c   Asante, Andrew ^d   Allred, Clinton ^b   Weaver, Evelyn A ^b   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Department of Electrical and Computer Engineering   (United States)

^d ALABAMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BUTYRIC ACID DERIVATIVE; LIGAND; PROPIONIC ACID DERIVATIVE; VOLATILE FATTY ACID;

ANIMAL; CACO-2 CELL LINE; CELL CULTURE; CHEMISTRY; COLON; COLON TUMOR; CYTOLOGY; DRUG EFFECT; GENE KNOCKOUT; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; MOUSE;

ANIMALS; BUTYRATES; CACO-2 CELLS; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; FATTY ACIDS, VOLATILE; GENE KNOCKOUT TECHNIQUES; GENE REGULATORY NETWORKS; HUMANS; LIGANDS; MICE; PROPIONATES; RECEPTORS, ARYL HYDROCARBON;

EID: 85028654025     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10824-x     Document Type: Article

References (53)

1. Poland, A., Glover, E. & Kende, A. S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 251, 4936-4946 (1976).
2. Hankinson, O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340 (1995).
3. Whitlock, J. P. Jr. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39, 103-125 (1999).
4. Fernandez-Salguero, P., Hilbert, D. M., Rudikoff, S., Ward, J. M. & Gonzalez, F. J. Aryl hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol. 140, 173-179 (1996).
5. Gonzalez, F. J. & Fernandez-Salguero, P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab. Dispos. 26, 1194-1198 (1998).
6. Lahvis, G. P. et al. The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol. 67, 714-720 (2005).
7. Benedict, J. C., Lin, T. M., Loeffler, I. K., Peterson, R. E. & Flaws, J. A. Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol. Sci. 56, 382-388 (2000).
8. Lund, A. K., Goens, M. B., Nunez, B. A. & Walker, M. K. Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice. Toxicol. Appl. Pharmacol. 212, 127-135 (2006).
9. McMillan, B. J. & Bradfield, C. A. The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol. Pharmacol. 72, 487-498 (2007).
10. Marshall, N. B. & Kerkvliet, N. I. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann. N. Y. Acad. Sci. 1183, 25-37 (2010).
11. Hao, N. & Whitelaw, M. L. The emerging roles of AhR in physiology and immunity. Biochem. Pharmacol. 86, 561-570 (2013).
12. Stevens, E. A., Mezrich, J. D. & Bradfield, C. A. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 127, 299-311 (2009).
13. Busbee, P. B., Rouse, M., Nagarkatti, M. & Nagarkatti, P. S. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr. Rev. 71, 353-369 (2013).
14. Esser, C. Biology and function of the aryl hydrocarbon receptor: report of an international and interdisciplinary conference. Arch. Toxicol. 86, 1323-1329 (2012).
15. Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E. & Zhao, B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124, 1-22 (2011).
16. Safe, S., Chadalapaka, G. & Jutooru, I. In The Ah Receptor in Biology and Toxicology (ed. R. Pohjanvirta) Ch. 24, 331-342 (John Wiler & Sons, 2012).
17. Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565 (2011).
18. Monteleone, I. et al. Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut. J Crohns Colitis 10, 670-677 (2016).
19. Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372-385 (2013).
20. Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13, 144-151 (2012).
21. Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221-225 (2015).
22. Monteleone, I. et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141, 237-248, 248 e231 (2011).
23. Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92-104 (2012).
24. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629-640 (2011).
25. Singh, N. P. et al. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One 6, e23522 (2011).
26. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455 (2013).
27. Bachmann, M., Meissner, C., Pfeilschifter, J. & Muhl, H. Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells. Biofactors, In press (2016).
28. Fung, K. Y., Cosgrove, L., Lockett, T., Head, R. & Topping, D. L. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br. J. Nutr. 108, 820-831 (2012).
29. Segain, J. P. et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47, 397-403 (2000).
30. Cheng, Y. et al. Editor's Highlight: Microbial-Derived 1,4-Dihydroxy-2-naphthoic Acid and Related Compounds as Aryl Hydrocarbon Receptor Agonists/Antagonists: Structure-Activity Relationships and Receptor Modeling. Toxicol. Sci. 155, 458-473 (2017).
31. Garrison, P. M., Rogers, J. M., Brackney, W. R. & Denison, M. S. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. Arch. Biochem. Biophys. 374, 161-171 (2000).
32. Schnekenburger, M., Peng, L. & Puga, A. HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim. Biophys. Acta 1769, 569-578 (2007).
33. Jin, U. H. et al. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol. Pharmacol. 85, 777-788 (2014).
34. Cheng, Y. et al. Aryl Hydrocarbon Receptor Activity of Tryptophan Metabolites in Young Adult Mouse Colonocytes. Drug Metab. Dispos. 43, 1536-1543 (2015).
35. Hubbard, T. D., Murray, I. A. & Perdew, G. H. Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation. Drug Metab. Dispos. 43, 1522-1535 (2015).
36. Hubbard, T. D. et al. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep. 5, 12689 (2015).
37. Kiefer, J., Beyer-Sehlmeyer, G. & Pool-Zobel, B. L. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. Br. J. Nutr. 96, 803-810 (2006).
38. Waldecker, M., Kautenburger, T., Daumann, H., Busch, C. & Schrenk, D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 19, 587-593 (2008).
39. Rooks, M. G. & Garrett, W. S. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341-352 (2016).
40. Lukens, J. R. et al. Dietary modulation of the microbiome affects autoinflammatory disease. Nature 516, 246-249 (2014).
41. Thorburn, A. N., Macia, L. & Mackay, C. R. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 40, 833-842 (2014).
42. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014).
43. Digby, J. E. et al. Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arterioscler. Thromb. Vasc. Biol. 32, 669-676 (2012).
44. Thangaraju, M. et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69, 2826-2832 (2009).
45. Korecka, A. et al. Bidirectional communication between the aryl hydrocarbon receptor (AhR) and the microbiome tunes host metabolism. Biofilms and Microbiomes 2, 16014 (2016).
46. Kekatpure, V. D., Dannenberg, A. J. & Subbaramaiah, K. HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. J. Biol. Chem. 284, 7436-7445 (2009).
47. Zapletal, O. et al. Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. Arch. Toxicol. (2016).
48. Haarmann-Stemmann, T. et al. Analysis of the transcriptional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines. Drug Metab. Dispos. 35, 2262-2269 (2007).
49. Schiering, C. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 542, 242-245 (2017).
50. Lamas, B. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598-605 (2016).
51. Murray, I. A., Nichols, R. G., Zhang, L., Patterson, A. D. & Perdew, G. H. Expression of the aryl hydrocarbon receptor contributes to the establishment of intestinal microbial community structure in mice. Sci. Rep. 6, 33969 (2016).
52. Fukumoto, S. et al. Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis. Immunol. Cell Biol. (2014).
53. Dey, A., Jones, J. E. & Nebert, D. W. Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochem. Pharmacol. 58, 525-537 (1999).